PL449753A1 - Receptura kosmetyczna zawierająca surowiec o nazwie INCI sh- Polypeptide-127 w każdym stężeniu - Google Patents

Receptura kosmetyczna zawierająca surowiec o nazwie INCI sh- Polypeptide-127 w każdym stężeniu

Info

Publication number
PL449753A1
PL449753A1 PL449753A PL44975324A PL449753A1 PL 449753 A1 PL449753 A1 PL 449753A1 PL 449753 A PL449753 A PL 449753A PL 44975324 A PL44975324 A PL 44975324A PL 449753 A1 PL449753 A1 PL 449753A1
Authority
PL
Poland
Prior art keywords
extract
concentration
inci
brassica oleracea
sophora japonica
Prior art date
Application number
PL449753A
Other languages
English (en)
Inventor
Grzegorz Sychowski
Original Assignee
Cell Cosmetics Spółka Z Ograniczoną Odpowiedzialnością
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cell Cosmetics Spółka Z Ograniczoną Odpowiedzialnością filed Critical Cell Cosmetics Spółka Z Ograniczoną Odpowiedzialnością
Priority to PL449753A priority Critical patent/PL449753A1/pl
Publication of PL449753A1 publication Critical patent/PL449753A1/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10General cosmetic use
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Cosmetics (AREA)

Abstract

Przedmiotem zgłoszenia są kompozycje kosmetyczne zawierające surowiec sh-Polypeptide-127 w każdym stężeniu oraz co najmniej jedną substancję i/lub mieszaninę substancji aktywnych wybranych spośród: ekstrakt z rukwi wodnej w stężeniu 0-10% (INCI: Nasturtium Officinale Extract, Nasturtium Officinale Leaf Extract, Nasturtium Officinale Flower/Leaf Extract, Nasturtium Officinale Flower Extract); ekstrakt z kabaczka w stężeniu 0-10% (INCI: Cucurbita Pepo Giromontiina Fruit Extract); ekstrakt z brokułów w stężeniu 0-10% (INCI: Brassica Oleracea Italica Extract, Brassica Oleracea Italica Juice, Brassica Oleracea Italica Seed Extract, Brassica Oleracea Italica LEaf/RootExtract, Brassica Oleracea Italica Sprout Extract); ekstrakt z jarmużu w stężeniu 0-10% (INCI: Brassica Oleracea Acephala Extract, Brassica Oleracea Acephala Sprout Extract, Brassica Oleracea Acephala Leaf Extract); ekstrakt z rzepy w stężeniu 0-10% (INCI: Raphanus Sativus Extract, Raphanus Sativus Sprout Extract, Raphanus Sativus Sprout Juice, Raphanus Sativus Root Extract, Raphanus Sativus Leaf Extract, Raphanus Sativus Seed Extract); ekstrakt z brukselki w stężeniu 0-10% (INCI: Brassica Oleracea Gemmifera Extract); ekstrakt z gorzknika kanadyjskiego w stężeniu 0-10% (INCI: Hydrastis Canadensis Extract, Hydrastis Canadensis Root Extract); ekstrakt z berberysu w stężeniu 0-10% (INCI: Berberis Vulgaris Root Extract);, ekstrakt z perełkowca japońskiego w stężeniu 0-10% (INCI: Sophora Japonica Extract, Sophora Japonica Branch Extract, Sophora Japonica Fruit Extract, Sophora Japonica Callus Culture Extract, Sophora Japonica Root Extract, Sophora Japonica Bud Extract, Sophora Japonica Leaf Extract, Sophora Japonica Flower Extract); Kwercetynę w stężeniu do 5% (INCI: Quercetin); Sulforafan w stężeniu do 5% (INCI: SulSulforaphane). Dodatkowo zawiera dodatek emulgatorów i koemulgatorów zawierających co najmniej stearynian glicerolu, alkohol cetylostearylowy, kwas stearynowy, alkohol cetylowy. Kompozycje kosmetyczne zawierają też dopuszczalne kosmetycznie zagęstniki np. gumę ksantanową w ilości od 0,05% do 2% wag., dodatki utrwalające, takie jak, sorbinian potasu i/lub benzoesan sodu w ilości 1-5% wag. oraz caprylat glicerolu oraz undecylenat glicerolu. Kompozycje kosmetyczne zawierają także dopuszczalne kompozycje zapachowe w ilości do 2% wag.
PL449753A 2024-09-06 2024-09-06 Receptura kosmetyczna zawierająca surowiec o nazwie INCI sh- Polypeptide-127 w każdym stężeniu PL449753A1 (pl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL449753A PL449753A1 (pl) 2024-09-06 2024-09-06 Receptura kosmetyczna zawierająca surowiec o nazwie INCI sh- Polypeptide-127 w każdym stężeniu

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL449753A PL449753A1 (pl) 2024-09-06 2024-09-06 Receptura kosmetyczna zawierająca surowiec o nazwie INCI sh- Polypeptide-127 w każdym stężeniu

Publications (1)

Publication Number Publication Date
PL449753A1 true PL449753A1 (pl) 2026-03-09

Family

ID=98976683

Family Applications (1)

Application Number Title Priority Date Filing Date
PL449753A PL449753A1 (pl) 2024-09-06 2024-09-06 Receptura kosmetyczna zawierająca surowiec o nazwie INCI sh- Polypeptide-127 w każdym stężeniu

Country Status (1)

Country Link
PL (1) PL449753A1 (pl)

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Baza danych COSMILE Europe; Baza danych COSMILE Europe; wpis dotyczący „SH-Polypeptide-127" udostępniony w dniu 2023-02-15 na stronie internetowej pod adresem: https://cosmileeurope.eu/inci/detail/28860/sh-polypeptide-127/ *
Baza danych Komisji Europejskiej CosIng; Baza danych Komisji Europejskiej CosIng; wpis dotyczący „SH-Polypeptide-127" udostępniony w dniu 2023-11-07 na stronie internetowej pod adresem: https://ec.europa.eu/growth/tools-databases/cosing/details/98422 *
Produkt kosmetyczny Cell Cosmetics Protection Face Cream P53 Protein; Produkt kosmetyczny Cell Cosmetics Protection Face Cream P53 Protein, dostępny na stronie internetowej pod adresem: https://manibeauty.pl/pl/p/Cell-Cosmetics-Protection-Face-Cream-P53-Protein-Serum-do-twarzy-30ml/94571, udostępniony publiczne w 2019 r. (na podstawie opinii konsumenckich opublikowanych online) *

Similar Documents

Publication Publication Date Title
Pereira et al. Synergisms in antioxidant and anti-hepatocellular carcinoma activities of artichoke, milk thistle and borututu syrups
JPH0761916A (ja) 皮膚外用剤
BRPI0707286A2 (pt) método de promoção de crescimento por aumento de colheitas agrìcolas e hortìculas
JP2022046628A (ja) 1-アミノ-1-シクロプロパンカルボン酸配合物
Morris et al. Variability for Sennoside A and B concentrations in eight Senna species
CN103828812B (zh) 含寡糖与吡啶类杀菌成分的组合物
Mali et al. Overview of Pharmacognostical and Pharmacological properties of Moringa oleifera
Ansori A mini-review of the medicinal properties of Okra (Abelmoschus esculentus l.) and potential benefit against SARS-CoV-2
EP1853292B1 (de) Pharmazeutische zusammensetzung enthaltend glutathion verbindungen und betalaine zur prävention und zur bekämpfung von krebs
KR102576779B1 (ko) 아시아티코사이드 함량이 증대된 병풀 추출물 및 이의 용도
Dubey et al. Ethnobotany of Dillenia pentagyna Roxb. in vindhya region of Madhya Pradesh, India
PL449753A1 (pl) Receptura kosmetyczna zawierająca surowiec o nazwie INCI sh- Polypeptide-127 w każdym stężeniu
US11547645B2 (en) Organic UVA filter-stabilized antioxidant composition
KR101809545B1 (ko) 항산화 활성을 가지는 화장료 조성물
Al Naqbi et al. Exploring the antioxidant potential of medicinal plants in the United Arab Emirates (UAE): Emphasizing their significance in novel drug development
Dutta et al. The active chemical constituent and biological activity of Salvadora persica (Miswak)
US20220202671A1 (en) Metal sequestering cosmetic composition
DE102012215511A1 (de) Verfahren zur Herstellung einer Bispyridiniumalkan enthaltenden halbfesten Zubereitung
US20220192961A1 (en) Hydroglycolic cosmetic composition with a high active content
KR101984166B1 (ko) 담죽엽, 율초 및 구맥의 추출물을 포함하는 피부 자극 완화용 화장료 조성물
JPH05320063A (ja) 活性酸素抑制剤
Gappar et al. Chemical composition and potential pharmacological properties of field horsetail extract based on GC-MS analysis
Mahar et al. Cultivation and biomedical application of Cissus quadrangularis L. in bone fracture
KR101833025B1 (ko) 희렴 추출물을 포함하는 여드름 개선용, 예방 및 치료용 조성물
KR20160052085A (ko) 개구리밥 추출물을 함유하는 알러지 완화용 피부외용제 조성물